Key Takeaways
- $1.8B Push: U.S. agencies and tech giants are backing AI biology data.
- Faster Research: Biohub aims to accelerate drug development with AI.
- Tech Race: Google, Meta, Anthropic, and OpenAI are investing in AI biology.
The U.S. government, Google and Meta are joining Biohub in a $1.8 billion AI Biology effort to build open biological datasets and accelerate drug development.
Tech Giants Back Open Biology Data
Meta, Google DeepMind and drug-discovery company Isomorphic Labs are jointly investing $300 million in the Virtual Biology Initiative, Biohub said Wednesday. The U.S. Department of Energy will invest more than $500 million over five years in laboratory measurement, modeling and computing.
The National Institutes of Health will coordinate datasets and repositories created through more than $500 million in earlier federal funding. Biohub will standardize that information so it can use it to train artificial intelligence models for biological research.
The initiative builds on the $500 million Biohub committed to the project in April. Biohub is a philanthropic organization founded by Meta CEO Mark Zuckerberg and his wife, Dr. Priscilla Chan.
Chan said the project aims to create a shared scientific resource rather than keep the resulting data within a single organization.
Biohub Targets Billions Of Cells
The initiative will study how cells respond to different conditions and use those measurements to develop predictive AI models. Researchers hope the approach can eventually shorten drug development timelines that currently take years.
Biohub’s head of science, Alex Rives, said existing biological datasets contain hundreds of millions of cells, while more advanced predictive models could require billions and eventually trillions of cells.
The project will use technologies including spatial transcriptomics, which maps molecular activity within intact tissue, along with large-scale experiments measuring how cells react to environmental changes.
Biohub expects the work to compress decades of biological data collection into about five years. Rives said the first dataset could be ready in roughly a year, while accurate predictive models could emerge within five years.
Private Investment Accelerates AI Research
The initiative combines public funding with private investment while maintaining an open-science model. Commercial funders will receive temporary access to some datasets before they are released publicly, giving participating companies an early opportunity to develop their own research.
Rives said the government-funded work will not carry those restrictions. Biohub also plans to seek additional funding from pharmaceutical companies and philanthropic organizations.
The move comes as major AI companies increase investment in biological research. Anthropic has established a wet laboratory for biology research, while the OpenAI Foundation launched a grant program worth more than $125 million to support biological and medical datasets for AI research.
The growing investment reflects the technology industry’s expanding interest in using AI to understand biological systems, identify potential drug targets, and speed up medical research.
